Cloning and Characterization of Mouse Nucleoside Triphosphate Diphosphohydrolase-8,
- 13 April 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (18) , 5511-5519
- https://doi.org/10.1021/bi0362222
Abstract
A novel mammalian plasma membrane bound nucleoside triphosphate diphosphohydrolase (NTPDase), named NTPDase8, has been cloned and characterized. Analysis of cDNA reveals an open reading frame of 1491 base pairs encoding a protein of 497 amino acid residues with an estimated molecular mass of 54650 Da and a predicted isoelectric point of 5.94. In a mouse, the genomic sequence is located on chromosome 2A3 and is comprised of 10 exons. The deduced amino acid sequence reveals eight putative N-glycosylation sites, two transmembrane domains, five apyrase-conserved regions, and 20-50% amino acid identity with other mammalian NTPDases. mRNA expression was detected in liver, jejunum, and kidney. Both intact cells and crude cell lysates from COS-7 cells expressing NTPDase8 hydrolyzed P2 receptor agonists, namely, ATP, ADP, UTP, and UDP, but did not hydrolyze AMP. There was an absolute requirement for divalent cations for the catalytic activity (Ca(2+) > Mg(2+)) with an optimal pH between 5.5 and 8.0 for ATP and 6.4 for ADP hydrolysis. Kinetic parameters derived from analysis of crude cell lysates showed that the enzyme had lower apparent K(m) values for adenine nucleotides and for triphosphonucleosides (K(m,app) of 13 microM for ATP, 41 microM for ADP, 47 microM for UTP, and 171 microM for UDP). Hydrolysis of triphosphonucleosides resulted in a transient accumulation of the corresponding diphosphonucleoside, as expected from the apparent K(m) values. Enzymatic properties of NTPDase8 differ from those of other NTPDases suggesting an alternative way to modulate nucleotide levels and consequently P2 receptor activation.Keywords
This publication has 19 references indexed in Scilit:
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brainJournal of Clinical Investigation, 2002
- Molecular Physiology of P2X ReceptorsPhysiological Reviews, 2002
- Ectonucleotidases: Some recent developments and a note on nomenclatureDrug Development Research, 2001
- First Apyrase Splice Variants Have Different Enzymatic PropertiesPublished by Elsevier ,2000
- Functional expression of a cDNA encoding a human ecto‐ATPaseBritish Journal of Pharmacology, 1999
- Glycoprotein reglucosylation and nucleotide sugar utilization in the secretory pathway: identification of a nucleoside diphosphatase in the endoplasmic reticulumThe EMBO Journal, 1999
- The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.Journal of Clinical Investigation, 1997
- Identification and Characterization of CD39/Vascular ATP DiphosphohydrolaseJournal of Biological Chemistry, 1996
- Sequential hydrolysis of the γ- and β-phosphate groups of ATP by the ATP diphosphohydrolase from pig pancreasBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983